Related Experiment Video
Updated: Nov 2, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Demographics and risk factors for pediatric recurrent acute pancreatitis
Cheryl E Gariepy1, Chee Y Ooi2, Asim Maqbool3
1Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio, USA.
Insights
Recurrent acute pancreatitis (RAP) in children is a significant concern, often leading to chronic disease. Identifying risk factors is crucial for developing effective treatments to prevent further episodes and complications.
Area of Science:
- Pediatric Gastroenterology
- Pancreatology
- Autoimmune Disorders
Background:
- Recurrent acute pancreatitis (RAP) affects 20-30% of children after an initial episode.
- Progression to chronic pancreatitis can occur over time.
- Identifying risk factors is key for therapeutic interventions.
Purpose of the Study:
- To review recent findings on risk factors and disease progression in pediatric recurrent acute pancreatitis.
- To highlight the impact of various conditions on pancreatitis risk in children.
Main Methods:
- Literature review of recent studies on pediatric pancreatitis.
- Analysis of risk factors including obesity, cystic fibrosis, Crohn disease, and ulcerative colitis.
Main Results:
- Obesity is linked to increased biliary stone disease and severe acute pancreatitis.
- Cystic fibrosis and CFTR-related disorders can present as RAP.
- Children with Crohn disease have a higher risk of acute pancreatitis; ulcerative colitis is associated with pediatric autoimmune pancreatitis.
Conclusions:
- Pediatric RAP is a painful condition causing gland destruction and insufficiency.
- Risk factors are increasingly understood, but preventive treatments are still needed.
Purpose Of Review:
Approximately 20-30% of children who experience one episode of acute pancreatitis will have at least one additional episode. For some children, pancreatitis recurs multiple times and in a few years is followed by the diagnosis of chronic pancreatitis. Identifying risk factors for recurrent episodes and disease progression is critical to developing therapeutic interventions.
Recent Findings:
Obesity is driving an increase in biliary stone disease and severe acute pancreatitis. Recurrent acute pancreatitis (RAP) may lead to the development of diabetes through autoimmune mechanisms. Cystic fibrosis or CFTR-related disorders may present as RAP and CFTR modulator therapy can increase or decrease the risk of acute pancreatitis in these populations. Children with Crohn disease have a three-fold risk of acute pancreatitis over the general population while children with ulcerative colitis are at increased risk for pediatric autoimmune pancreatitis, a disorder that may be distinct from autoimmune pancreatitis described in adults. Obstructive jaundice in the absence of identified mechanical factors may be a presenting sign of pediatric autoimmune pancreatitis.
Summary:
Pediatric RAP is a painful condition that leads to gland destruction and functional insufficiency. Risk factors are being clarified but preventive treatments remain elusive.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism

